Literature DB >> 19747841

Depression as a risk factor for osteoporosis.

Giovanni Cizza1, Svetlana Primma, Gyorgy Csako.   

Abstract

Osteoporosis is a major public health threat. Multiple studies have reported an association between depression and low bone mineral density, but a causal link between these two conditions is disputed. Here we review the endocrine and immune alterations secondary to depression that might affect bone mass. We also discuss the possible role of poor lifestyle in the etiology of osteoporosis in subjects with depression and the potential effect of antidepressants on bone loss. We propose that depression induces bone loss and osteoporotic fractures, primarily via specific immune and endocrine mechanisms, while poor lifestyle habits and use of specific antidepressants are potential contributory factors.

Entities:  

Mesh:

Year:  2009        PMID: 19747841      PMCID: PMC2764354          DOI: 10.1016/j.tem.2009.05.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  60 in total

1.  Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.

Authors:  Richard Hubbard; Paddy Farrington; Chris Smith; Liam Smeeth; Anne Tattersfield
Journal:  Am J Epidemiol       Date:  2003-07-01       Impact factor: 4.897

2.  Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls.

Authors:  Lorah D Dorn; Elizabeth J Susman; Stephanie Pabst; Bin Huang; Heidi Kalkwarf; Susannah Grimes
Journal:  Arch Pediatr Adolesc Med       Date:  2008-12

Review 3.  Central control of bone remodelling.

Authors:  S Takeda
Journal:  J Neuroendocrinol       Date:  2008-06       Impact factor: 3.627

4.  Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder.

Authors:  Kai G Kahl; Wiebke Greggersen; Sebastian Rudolf; Beate M Stoeckelhuber; Claudia U Bergmann-Koester; Leif Dibbelt; Ulrich Schweiger
Journal:  Psychosom Med       Date:  2006 Sep-Oct       Impact factor: 4.312

5.  Bone mineral density in premenopausal women with major depressive disorder.

Authors:  Kâzim M Yazici; Ayşen Akinci; Ayşegül Sütçü; Levent Ozçakar
Journal:  Psychiatry Res       Date:  2003-03-25       Impact factor: 3.222

6.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

7.  Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study.

Authors:  Felice N Jacka; Julie A Pasco; Margaret J Henry; Mark A Kotowicz; Seetal Dodd; Geoff C Nicholson; Michael Berk
Journal:  Menopause       Date:  2005 Jan-Feb       Impact factor: 2.953

8.  Depression and chronic medical illnesses in Asian older adults: the role of subjective health and functional status.

Authors:  Matthew Niti; Tze-Pin Ng; Ee Heok Kua; Roger Chun Man Ho; Chay Hoon Tan
Journal:  Int J Geriatr Psychiatry       Date:  2007-11       Impact factor: 3.485

9.  Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Authors:  P Ravn; G Cizza; N H Bjarnason; D Thompson; M Daley; R D Wasnich; M McClung; D Hosking; A J Yates; C Christiansen
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

10.  Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Authors:  M M Bliziotes; A J Eshleman; X W Zhang; K M Wiren
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

View more
  48 in total

Review 1.  Depression and osteoporosis: a research synthesis with meta-analysis.

Authors:  G Cizza; S Primma; M Coyle; L Gourgiotis; G Csako
Journal:  Horm Metab Res       Date:  2010-05-07       Impact factor: 2.936

2.  Keep the 'phospho' on MAPK, be happy.

Authors:  Schahram Akbarian; Roger J Davis
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

3.  Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition.

Authors:  Pauline M Maki; Ellen W Freeman; Gail A Greendale; Victor W Henderson; Paul A Newhouse; Peter J Schmidt; Nelda F Scott; Carol A Shively; Claudio N Soares
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

4.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

5.  Depression is associated with increased incidence of osteoporotic thoracolumbar fracture in postmenopausal women: a prospective study.

Authors:  Yaqi Zong; Yanming Tang; Yuan Xue; Huairong Ding; Zhiyang Li; Dong He; Ying Zhao; Pei Wang
Journal:  Eur Spine J       Date:  2015-05-23       Impact factor: 3.134

Review 6.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 7.  Update on primary ovarian insufficiency.

Authors:  Meghan Hewlett; Shruthi Mahalingaiah
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

Review 8.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

9.  Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats.

Authors:  Valeria Sibilia; Francesca Pagani; Elisa Dieci; Emanuela Mrak; Marcella Marchese; Guido Zarattini; Francesca Guidobono
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

10.  Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.

Authors:  Rosimary S Carvalho; Carolina M de Souza; Julliana C S Neves; Sergio A Holanda-Pinto; Lívia M S Pinto; Gerly A C Brito; Geanne M de Andrade
Journal:  J Negat Results Biomed       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.